The Effects of Orange Juice on Insulin Sensitivity and Plasma Lipids

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Florida Department of Citrus
Information provided by (Responsible Party):
University of Nottingham
ClinicalTrials.gov Identifier:
NCT01201603
First received: September 13, 2010
Last updated: June 13, 2012
Last verified: June 2012

September 13, 2010
June 13, 2012
July 2010
December 2011   (final data collection date for primary outcome measure)
Insulin sensitivity ('M' value) [ Time Frame: after 3 months' intervention ] [ Designated as safety issue: No ]
Insulin sensitivity (mg glucose disposal from the blood/kg body weight/min)calculated from glucose disposal during a hyperinsulinemic, euglycemic glucose clamp
Same as current
Complete list of historical versions of study NCT01201603 on ClinicalTrials.gov Archive Site
  • Glucose Oxidation rate [ Time Frame: after 3 months' intervention period ] [ Designated as safety issue: No ]
    Measured by ventilated hood indirect calorimetry
  • High Density Cholesterol [ Time Frame: after 3 months' intervention ] [ Designated as safety issue: No ]
    Serum HDL concentration
  • Low density cholesterol [ Time Frame: after 3 months' intervention ] [ Designated as safety issue: No ]
    Serum LDL concentration
  • Gene expression in adipose tissue [ Time Frame: after 3 months' intervention ] [ Designated as safety issue: No ]
    Expression of genes related to insulin sensitivity in adipose tissue
Same as current
Not Provided
Not Provided
 
The Effects of Orange Juice on Insulin Sensitivity and Plasma Lipids
The Effects of Orange Juice on Insulin Sensitivity and Plasma Lipids

The aim of this study is primarily to investigate the ability of antioxidants found in orange juice (OJ) to increase the body's sensitivity to the hormone insulin. Overweight or mildly obese women, who are otherwise healthy, will be recruited. The time commitment for subjects is ~14wks. Subjects will attend the laboratory on 5 occasions after fasting from midnight. The 1st is a medical screening. Laboratory visits 2 & 5 will take ~5hrs and will be separated by 3 months, during which time subjects will consume 250ml of an orange drink (either OJ or an orange flavoured control drink) once a day. During visits 2 & 5, subjects will have a scan to assess their %body fat using a low-dose x-ray machine, and have their insulin sensitivity measured using a technique called a 'Glucose Clamp'. During the 3hr glucose clamp, subjects receive an infusion of the hormone insulin and a glucose solution directly into their blood stream, with insulin sensitivity determined from the amount of glucose required to maintain blood glucose at normal levels. In addition, a small sample of fat tissue (about the size of a haricot bean) will be taken from underneath the skin of the belly. Subjects will record their food intake for 3-days in weeks 3, 7 and 11 of consuming the drink, and come to the lab for visits 3&4 during weeks 4&8. Laboratory visits 3&4 repeat measurements taken in the 1st (screening) visit.

Background:

Overweight and mild obesity are associated with insulin resistance and mild elevations in lipid risk factors which are not usually sufficiently abnormal to merit treatment. Such people are encouraged to lose weight to reduce their risk of progressing to type 2 diabetes and coronary heart disease, but there is clearly a potential role for dietary modifications to maximize any potential benefit of this weight loss. Flavonoids are known to have vascular effects which might enhance substrate delivery to metabolically active tissues, and thus improve insulin sensitivity. There are many different dietary sources of flavonoids, with fruits such as apples, berries and citrus being rich sources. However, some researchers have expressed concern that a high dietary intake of 100% juice may contribute to the development of insulin resistance, obesity and the Metabolic Syndrome (Bazzano, Li et al. 2008), although this is not universally accepted (Fujioka, Greenway et al. 2006; O'Neil and Nicklas 2008). To date, there have been no studies investigating the effects of citrus fruits on indices of cardio-metabolic health in people who are presently healthy but are at risk of developing some features of the Metabolic Syndrome.

Aims:

To investigate the effects of orange juice (OJ) intake on insulin sensitivity, appetite hormones, blood pressure and plasma lipids. In addition we aim to investigate any gene expression changes associated with OJ consumption, in particular in adipose tissue.

Experimental protocol and methods:

Overweight or obese women (BMI 27-35), who are otherwise healthy, will be recruited onto the study. They will attend the 'David Greenfield Human Physiology' laboratories on 5 convenient mornings, following an overnight fast. The 1st visit is a medical screening and will involve signing a consent form, completing medical screening, food frequency and activity questionnaires, having height, weight, and hip/waist circumference measurements taken and a sample of blood taken for CBC, urea, electrolytes, LFT, TFT, glucose and insulin analysis. Subjects will then be asked to complete a 3-day diet diary for macronutrient assessment and to consume a diet providing 50% of energy as carbohydrate for 3 days prior to the 2nd laboratory visit. This 2nd visit will involve having a DEXA body composition scan, an adipose tissue biopsy and a 3-hr hyperinsulinemic, euglycemic glucose clamp. Starting on the following morning, subjects will then consume an orange drink (either OJ or a carbohydrate matched orange flavoured drink) once a day for 12 wks. A 3-day diet diary for macronutrient assessment will be recorded during wks 3,7and 11 of taking the drink, and measurements made at screening will be repeated on visits 3 and 4 which will take place in weeks 4 and 8. A standardized diet will be consumed for 3 days prior to the final laboratory visit, as before. This 5th visit will be identical to visit 2.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
  • Insulin Resistance
  • Obesity
Dietary Supplement: orange juice
250ml of orange juice or a sugars matched orange drink
  • Experimental: Orange Juice
    Intervention: Dietary Supplement: orange juice
  • Placebo Comparator: Orange drink
    Sugars matched orange drink
    Intervention: Dietary Supplement: orange juice

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
32
December 2012
December 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • pre-menopausal or post-menopausal and taking HRT
  • BMI 27-35kg/m2
  • HOMA-IR value > 1.5
  • healthy

Exclusion Criteria:

  • pregnant or breast feeding,
  • any metabolic or endocrine abnormalities,
  • clinically significant abnormalities on screening,
  • fasting glucose > 6.0mmol/l,
  • taking medication other than the contraceptive pill or HRT
  • herbal supplement use,
  • food allergies/intolerances related to the investigational product (citrus juices, fructose)
  • daily consumption of >100ml citrus juices
Female
18 Years to 55 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United Kingdom
 
NCT01201603
RIS 100058
No
University of Nottingham
University of Nottingham
Florida Department of Citrus
Principal Investigator: Ian A Macdonald, PhD University of Nottingham
University of Nottingham
June 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP